Orthopaedics and Trauma
Volume 23, Issue 4 , Pages 258-265 , August 2009

(v) The non-surgical management of musculoskeletal malignancy

References 

  1. Cancer Research UK . In:  Toms JR editors. CancerStats monograph. 2004;
  2. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80(Suppl):1588–1594
  3. Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy – a systematic review of randomized trials. Clin Oncol. 2003;15:345–352
  4. Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25:1423–1436
  5. Wu JSY, Wong R, Johnston M, et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2006;55:594–605
  6. Hird A, Zhang L, Holt T, et al. Dexamethasone for the prophylaxis of radiation induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clin Oncol. 2009;21:329–335
  7. Poulter C, Cosmatos D, Rubin P, et al. A report of RTOG 82-06: a phase III study of whether the addition of a single dose hemibody irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys. 1992;23:207–214
  8. Quilty PM, Kirk D, Bolger JJ, et al. A comparison of the palliative effects of strontium 89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol. 1994;31:33–40
  9. Ross JR, Saunders Y, Edmonds PM, et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003;327:469–475
  10. Pavlakis N, Stockler M. Bisphosphonates for breast cancer. In: The Cochrane Library, Issue 1. Oxford: Update Software; 2002;
  11. Berenson JR, Lichtenstein A, Porter L, et al., Myeloma Aredia Study Group  Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med. 1996;334:488–493
  12. Saad F, Gleason DM, Murray R, et al., Zoledronic Acid Prostate Cancer Study Group  Long term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone refractory prostate cancer. J Natl Cancer Inst. 2004;96(11):879–882
  13. Rosen LS, Gordon D, Tchekmedyian NS, et al. Long term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non small lung cancer and other solid tumours: a randomised phase III double blind, placebo controlled trial. Cancer. 2004;100:2613–2621
  14. Eilber F, Giuliano A, Eckardt J, et al. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol. 1987;5(1):21–26
  15. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314(2):1600–1606
  16. Goorin AM, Schwartzentruber DJ, Devidas M, et al. Pre-surgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for non metastatic osteosarcoma: pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003;21(8):1574–1580
  17. Patricio MB, Vilhena M, Neves M, et al. Ewings' Sarcoma in children: twenty five years of experience at the Instituto Portuges do Oncologia de Francisico Gentil. J Surg Oncol. 1991;47:37–40
  18. Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1988;16:197–203
  19. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235–2241
  20. Woll PJ, van Glabbeke M, Hohenberger P, et al. Adjuvant chemotherapy with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): interim analysis of a randomised phase III trial. [abstract] J Clin Oncol. 2007;25:547s
  21. Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573
  22. Mitchell AD, Ayoub K, Mangham DC, Grimer RJ, et al. Experience in the treatment of dedifferentiated chondrosarcoma. J Bone Joint Surg. 2000;82B:55–61

PII: S1877-1327(09)00087-6

doi: 10.1016/j.mporth.2009.06.001

Orthopaedics and Trauma
Volume 23, Issue 4 , Pages 258-265 , August 2009